News
These healthcare leaders still could perform well in the long run. Even with all the volatility and the flirting with ...
For RFK Jr. and his antivax supporters and associates, aluminum adjuvants in some required children’s vaccines appear to be ...
During the hearing, an official from Novo Nordisk will be questioned about the pricing they charge for Ozempic and ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
A majority of Americans have experienced the frustration of getting a healthcare insurance denial, often times finding no ...
Pharmaceutical company Simtra has bought a 65-acre property from Cook Group, including a 300,000 square-foot facility, to ...
Explore more
Novo Nordisk A/S (NYSE:NVO) is one of the Best Extremely Profitable Stocks to Buy Right Now. On July 18, Novo Nordisk A/S ...
A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...
Goldman Sachs GQG Partners International Opportunities GSIMX has the elements in place to continue to outperform, though the road could be bumpy at times.
2d
Zacks Investment Research on MSNNovo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on ItNovo Nordisk (NVO) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of ...
China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results